Dragonboat Biopharmaceutical Company Limited

This study tests a new drug called BC006 in 96 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The trial has two parts: first, a small group gets BC006 to check safety, then a larger group is randomly assigned to rece…